Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders: Proceedings of the Round Table Conference. Rome, October 30 – 31, 1974

Front Matter....Pages I-XI
Introductory Remarks....Pages 1-2
Front Matter....Pages 3-3
The Platelet as an Inflammatory Cell....Pages 4-7
Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders....Pages 8-16
The Mathematical Analysis of the Human Platelet Aggregation Mechanism and Its Clinical Application....Pages 17-26
Quantitative Valuation of Platelet Aggregation Curves through the Calculation of a Numerical Index....Pages 27-32
The Polyunsaturated Fatty Acids in Human Platelets: Effects of Diet and Possible Functional Significance....Pages 33-43
Enhanced Platelet Aggregation as a Risk Factor for Progress and Complications of Vascular Disease. New Findings with a Platelet Aggregation Test (PAT III) and on the Dependence of Different Aggregation Tests on Morphologic Platelet Changes....Pages 44-62
Front Matter....Pages 63-63
Thrombosis and Embolism as a Cause of Ischemic Cerebrovascular Disturbances. Analysis from a Serie of 1000 Patients....Pages 64-74
Platelet Adhesiveness and Cerebral Vascular Disease Revisited....Pages 75-76
The Significance of Platelet Aggregation in Amaurosis Fugax....Pages 77-80
Mechanisms of Platelet 5-Hydroxytryptamine Release in Migraine....Pages 81-86
Experimental Observations on Platelet Emboli in Focal Brain Ischemia....Pages 87-92
Observations on Platelet Aggregability in the Acute Phase of Untreated Strokes....Pages 93-95
Microembolism in the Nervous System....Pages 96-109
Influence of Plasma Components in the Development of Conditions of Increased Platelet Aggregation Found in a Number of Vascular Diseases....Pages 110-114
Mechanism Associated with Platelet Adhesiveness in Cerebrovascular Disease....Pages 115-120
Regional Intravascular Coagulation and Microthrombosis in Traumatic Brain Lacerations in Man....Pages 121-128
Platelet Aggregation in Cerebrovascular Patients....Pages 129-133
In Vivo Effect of Cyclic AMP and Related Drugs on Platelet Function....Pages 134-135
Platelet Hyperreactivity and Decreased Survival in Chronic Cerebrovascular Patients. Chronic Defibrination Syndrome?....Pages 136-151
Front Matter....Pages 63-63
Arterial Hypertension and Platelet Aggregation in the Pathogenesis of Cerebrovascular Diseases....Pages 152-166
Smoking, Cerebrovascular Diseases and Platelet Functions....Pages 167-171
Contribution of Platelet Aggregation and Serotonin Release to Progressive Cerebral Infarction....Pages 172-178
Effect of Agents which Modify Platelet Aggregation and/or Coagulation on Experimental Platelet Embolism and Intravascular Coagulation....Pages 179-190
Platelet Abnormalities in Cerebrovascular Diseases....Pages 191-196
Inhibition of Platelet Aggregation by Synthetic Organic Acids: Quantitative Relationships Between Chemical Structures and Biological Activities....Pages 197-206
Some Observations of Platelet Changes in Atherosclerosis and Some Observations in the Platelet Alterations Before and After Antiaggregant Drugs in Normal and Atherosclerotics....Pages 207-214
Front Matter....Pages 215-215
Inhibition of Platelet Thrombus Formation by Pharmacological Agents....Pages 216-224
A Long-Term Clinical Trial with Antiplatelet Agents in Cerebrovascular Ischemia: Biological and Methodological Aspects....Pages 225-231
Effect of Aspirin and Dipyridamole on Platelet Function and on Neurologic Evaluation of Patients Affected by Stroke or Transient Ischemic Attacks....Pages 232-242
The Pharmacologic Control of the Enhanced Platelet Aggregation in Preventive Neurology....Pages 243-257
Aspirin in Cerebral Ischemia....Pages 258-261
The Canadian Cooperative Studies of the Effect of Platelet-Suppressing Drugs in Transient Cerebral Ischemic Attacks....Pages 262-267
On the Relationships Between the Activation of the Complement System and the Platelet Aggregation....Pages 268-279
Front Matter....Pages 281-281
Chairmen’s Considerations....Pages 282-288
Concluding Remarks....Pages 289-289
Back Matter....Pages 291-292